Abstract
To develop and validate a neural network for automated detection and segmentation of intracranial metastases on brain MRI studies obtained for stereotactic radiosurgery treatment planning. In this retrospective study, 413 patients (average age, 61 years ± 12 [standard deviation]; 238 women) with a total of 5202 intracranial metastases (median volume, 0.05 cm3; interquartile range, 0.02-0.18 cm3) undergoing stereotactic radiosurgery at one institution were included (January 2017 to February 2020). A total of 563 MRI examinations were performed among the patients, and studies were split into training (n = 413), validation (n = 50), and test (n = 100) datasets. A three-dimensional (3D) U-Net convolutional network was trained and validated on 413 T1 postcontrast or subtraction scans, and several loss functions were evaluated. After model validation, 100 discrete test patients, who underwent imaging after the training and validation patients, were used for final model evaluation. Performance for detection and segmentation of metastases was evaluated using Dice scores, false discovery rates, and false-negative rates, and a comparison with neuroradiologist interrater reliability was performed. The median Dice score for segmenting enhancing metastases in the test set was 0.75 (interquartile range, 0.63-0.84). There were strong correlations between manually segmented and predicted metastasis volumes (r = 0.98, P < .001) and between the number of manually segmented and predicted metastases (R = 0.95, P < .001). Higher Dice scores were strongly correlated with larger metastasis volumes on a logarithmically transformed scale (r = 0.71). Sensitivity across the whole test sample was 70.0% overall and 96.4% for metastases larger than 6 mm. There was an average of 0.46 false-positive results per scan, with the positive predictive value being 91.5%. In comparison, the median Dice score between two neuroradiologists was 0.85 (interquartile range, 0.80-0.89), with sensitivity across the test sample being 87.9% overall and 98.4% for metastases larger than 6 mm. A 3D U-Net-based convolutional neural network was able to segment brain metastases with high accuracy and perform detection at the level of human interrater reliability for metastases larger than 6 mm.Keywords: Adults, Brain/Brain Stem, CNS, Feature detection, MR-Imaging, Neural Networks, Neuro-Oncology, Quantification, Segmentation© RSNA, 2021.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.